| Literature DB >> 21172056 |
Shao Li1, Bo Zhang, Duo Jiang, Yingying Wei, Ningbo Zhang.
Abstract
BACKGROUND: Traditional Chinese Medicine (TCM) is characterized by the wide use of herbal formulae, which are capable of systematically treating diseases determined by interactions among various herbs. However, the combination rule of TCM herbal formulae remains a mystery due to the lack of appropriate methods.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21172056 PMCID: PMC3024874 DOI: 10.1186/1471-2105-11-S11-S6
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Examples for the numerical representation of herbal formulae
| Formula | herb1 | herb2 | herb3 | herb4 | herb5 | herb6 | herb7 | herb8 | herb9 | herb10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Formula 1 | 0 | 0.5 | 0 | 0.25 | 0 | 1 | 0 | 0 | 0.75 | 0 |
| Formula 2 | 0.375 | 0.625 | 0.875 | 0.125 | 0.75 | 0 | 1 | 0.25 | 0 | 0.5 |
| Formula 3 | 0.5 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
*Assume there are a total of 10 herbs denoted by herb1, herb2…herb10 (j=1, 2…,10), and three herbal formulae containing the following herbs in sequence (i=1,2,3): Formula 1: herb4, herb2, herb9 and herb6 (k=4); Formula 2: herb4, herb8, herb1, herb10, herb2, herb5, herb3 and herb7 (k=8); and Formula 3: herb1 and herb6 (k=2). For herb2 in Formula 1, we calculated that a =2 and b=2/4=0.5. The matrix representation for this artificial data set is shown in the table.
Top 10 herbs in 3865 Collaterals-related formulae
| Rank | Herbs in Collaterals-related herbal formula | Natural Property | Frequency | Angiogenesis activity [ | |
|---|---|---|---|---|---|
| Chinese Name | English Name | ||||
| 1 | Dang-gui | Warm | 49.50% | Pro-angiogenesis | |
| 2 | Gan-cao | Neutral | 38.37% | Anti-angiogenesis | |
| 3 | Chuan-xiong | Warm | 32.32% | Pro-angiogenesis | |
| 4 | Chi-shao | Cool | 30.79% | Pro-angiogenesis | |
| 5 | Dan-shen | Cool | 29.62% | Pro-/Anti-angiogenesis | |
| 6 | Niu-xi | Neutral | 26.39% | Unknown | |
| 7 | Huang-qi | Warm | 25.85% | Pro-angiogenesis | |
| 8 | Hong-hua | Warm | 24.94% | Unknown | |
| 9 | Di-huang | Cold | 24.92% | Pro-angiogenesis | |
| 10 | Bai-shao | Cool | 21.89% | Pro-angiogenesis | |
Top 20 DMIM-extracted herb pairs
| Rank | Herb 1 | Herb 2 | DMIM Score | ||||
|---|---|---|---|---|---|---|---|
| Chinese Name | English Name | Natural Property | Chinese Name | English Name | Natural Property | ||
| 1 | Mo-yao | Neutral | Ru-xiang | Warm | 2.9528 | ||
| 2 | Hong-hua | Warm | Tao-ren | Neutral | 1.8057 | ||
| 3 | E-zhu | Warm | San-len | Neutral | 0.97254 | ||
| 4 | Long-gu | Neutral | Mu-li | Cool | 0.78572 | ||
| 5 | Da-zao | Warm | Shen-jiang | Warm | 0.63477 | ||
| 6 | Quan-xie | Neutral | Wu-gong | Warm | 0.56607 | ||
| 7 | Du-huo | Warm | Qiang-huo | Warm | 0.45846 | ||
| 8 | Cang-zhu | Warm | Huang-bai | Cold | 0.43511 | ||
| 9 | Pu-huang | Neutral | Wu-ling-zhi | Warm | 0.42285 | ||
| 10 | Bai-zhu | Warm | Fu-ling | Neutral | 0.41082 | ||
| 11 | Shi-chang-pu | Warm | Yuan-zhi | Warm | 0.40238 | ||
| 12 | Chi-shao | Cool | Tao-ren | Neutral | 0.39792 | ||
| 13* | Jiang-can | Neutral | Quan-xie | Neutral | 0.3707 | ||
| 14 | Ban-xia | Warm | Chen-pi | Warm | 0.34629 | ||
| 15* | Dang-shen | Neutral | Huang-qi | Warm | 0.34084 | ||
| 16* | Chuan-xiong | Warm | Hong-hua | Warm | 0.32943 | ||
| 17* | Chuan-xiong | Warm | Tao-ren | Neutral | 0.31513 | ||
| 18 | Chuan-xiong | Warm | Dang-gui | Warm | 0.29861 | ||
| 19* | Chi-shao | Cool | Hong-hua | Warm | 0.29351 | ||
| 20* | Bai-zhu | Warm | Dang-shen | Neutral | 0.29154 | ||
| 195 | Bai-shao | Cool | Gan-cao | Neutral | 0.052203 | ||
*: Herb pairs extracted by DMIM but not recorded in traditionally-defined herb pairs.
Figure 1DMIM-extracted herb network from 3865 herbal formula.This herb network is constructed from the top 100 herb pairs extracted by DMIM. Herbs with different natural properties and six classical herbal formulae are presented in the network. Data about only two interacted herbs are not shown.
Figure 2Angiogenic activities of major ingredients in DMIM-extracted herbs. A. The extended hub module in DMIM-extracted herb network. Each node corresponds to a herb colored according to their natural properties. The size of each node is proportional to the number of herbs connecting to it. A solid line links a herb pair while the width of the lines is proportional to the DMIM score. B. Experimental results of the herb ingredients in the module. The pro- or anti-angiogenic effects of each herb were delineated by pro- or anti-angiogenic screening model respectively.
Figure 3Combination effects in DMIM-extracted herb pairs.According to the HSC model, the dose matrix indicates the combined response of TMP in combination with three other compounds at six different doses. The color of the gird denotes the level of cell growth stimulation or inhibition. The growth percentage and inhibition percentage were calculated by the pro- or anti-angiogenic screening model respectively (A, C and E). B, D and F show the calculated excess growth or inhibition percentage over the HSC additivity model. The percentage above or below zero denotes the combination with synergism or antagonism, respectively.
Enriched pathways of Liu-wei-di-huang genes and Liu-wei-di-huang-treated disease genes identified by DAVID
| Category | Enriched KEGG pathway | False discovery rate |
|---|---|---|
| hsa05200:Pathways in cancer | 1.82E-06 | |
| hsa05014:Amyotrophic lateral sclerosis | 3.82E-06 | |
| hsa04620:Toll-like receptor signaling pathway | 6.42E-06 | |
| hsa04660:T cell receptor signaling pathway | 1.56E-05 | |
| hsa04210:Apoptosis | 8.13E-04 | |
| hsa04621:NOD-like receptor signaling pathway | 0.002737 | |
| hsa05222:Small cell lung cancer | 0.00471 | |
| hsa04080:Neuroactive ligand-receptor interaction | 0.007635 | |
| hsa05210:Colorectal cancer | 0.03486 | |
| hsa05200:Pathways in cancer | 2.35E-12 | |
| disease genes | hsa05210:Colorectal cancer | 1.11E-07 |
| hsa05221:Acute myeloid leukemia | 2.58E-07 | |
| hsa05213:Endometrial cancer | 5.92E-07 | |
| hsa05220:Chronic myeloid leukemia | 9.79E-05 | |
| hsa05215:Prostate cancer | 1.38E-04 | |
| hsa04930:Type II diabetes mellitus | 2.25E-04 | |
| hsa05218:Melanoma | 3.68E-04 | |
| hsa05216:Thyroid cancer | 0.002937 | |
| hsa05214:Glioma | 0.005064 | |
| hsa05223:Non-small cell lung cancer | 0.008102 | |
| hsa04950:Maturity onset diabetes of the young | 0.01155 | |
| hsa05212:Pancreatic cancer | 0.019292 |
Figure 4The co-module underlying For the herb module, two herbs from the Liu-wei-di-huang are linked if they have common responsive genes. For the disease module, two diseases are linked if they have common disease genes. The width of the solid lines is scaled with the number of common herb or disease genes. All herb genes and disease genes are mapped to the protein-protein interaction network. A biomolecular module as a common network target and associated with both the herb module and the disease module is extracted with dashed lines.